FDA-approved injection Semaglutide & Tirzepatide helps adults lose weight. It works by helping to release hormones that decrease appetite and increase feelings of fullness.

Semaglutide mimics GLP-1, or glucagon-like peptide-1, which regulates appetite and food intake. Semaglutide binds to receptors in the stomach lining, slowing stomach emptying. As the stomach empties slowly, the brain is notified that the stomach is full, which results in a decrease in appetite. Tirzepatide activates receptors of TWO hormones secreted from the intestine, GLP-1 and GIP, to reduce appetite and food intake. Weight loss can be achieved safely and gradually with weekly injections of Semaglutide & Tirzepatide administered at Arctic Medical Center.

Benefits of Semaglutide & Tirzepatide include:

  • Reduces appetite
  • Safe weight loss
  • Reduces food cravings
  • Lowers blood sugar without causing hypoglycemia
  • Improves eating control
  • Enhances the brain’s sense of fullness
  • Increases the feeling of fullness by slowing gastric emptying in the intestines.
  • The dosage of Semaglutide & Tirzepatide will be determined by a variety of factors, such as the patient’s starting weight.

FAQ

The use of Semaglutide & Tirzepatide is not recommended for patients with medullary thyroid cancer (MTC) or MEN 2 (endocrine disorders). People with type I diabetes shouldn’t take Semaglutide & Tirzepatide.

Depending on the amount of weight you want to lose, Semaglutide & Tirzepatide programs vary in length.

In most cases, patients do not experience uncontrollable hunger. You will feel satisfied even with smaller portions. Semaglutide & Tirzepatide has no specific restrictions on what you can eat, but it is recommended that you eat a healthy diet.